Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Farlow

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 1, 2021
Head injury is associated with tau deposition on PET in MCI and AD patientsShannon L Risacher, John D West, Rachael Deardorff, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2015
Comprehensive gene- and pathway-based analysis of depressive symptoms in older adultsKwangsik Nho, Vijay K Ramanan, Emrin Horgusluoglu, et al.
Archives of Neurology|August 13, 2008
Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer diseaseAdam S Fleisher, Rema Raman, Eric R Siemers, et al.
Multimodal Brain Image Analysis : Third International Workshop, MBIA 2013, Held in Conjunction with MICCAI 2013, Nagoya, Japan, September 22, 2013 : Proceedings. MBIA (Workshop) (3Rd : 2013 : Nagoya-Shi, Japan)|November 11, 2014
<i>PARP1</i> gene variation and microglial activity on [<sup>11</sup>C]PBR28 PET in older adults at risk for Alzheimer's diseaseSungeun Kim, Kwangsik Nho, Shannon L Risacher, et al.
Neuroimage. Clinical|February 3, 2019
Resting state network modularity along the prodromal late onset Alzheimer's disease continuumJoey A Contreras, Andrea Avena-Koenigsberger, Shannon L Risacher, et al.
Brain Pathology (Zurich, Switzerland)|September 4, 2009
PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker diseaseVladimir Kepe, Bernardino Ghetti, Martin R Farlow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2023
Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN studyYing Xu, Htein Linn Aung, Randall J Bateman, et al.
Cell Reports|January 20, 2024
Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's diseaseMeichen Yu, Shannon L Risacher, Kwangsik T Nho, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Spatial transcriptomic patterns underlying regional vulnerability to amyloid-β and tau pathologies and their relationships to cognitive dysfunction in Alzheimer's diseaseMeichen Yu, Shannon L Risacher, Kwangsik T Nho, et al.
JAMA Neurology|April 19, 2016
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older AdultsShannon L Risacher, Brenna C McDonald, Eileen F Tallman, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 1, 2021
Head injury is associated with tau deposition on PET in MCI and AD patientsShannon L Risacher, John D West, Rachael Deardorff, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2015
Comprehensive gene- and pathway-based analysis of depressive symptoms in older adultsKwangsik Nho, Vijay K Ramanan, Emrin Horgusluoglu, et al.
Archives of Neurology|August 13, 2008
Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer diseaseAdam S Fleisher, Rema Raman, Eric R Siemers, et al.
Multimodal Brain Image Analysis : Third International Workshop, MBIA 2013, Held in Conjunction with MICCAI 2013, Nagoya, Japan, September 22, 2013 : Proceedings. MBIA (Workshop) (3Rd : 2013 : Nagoya-Shi, Japan)|November 11, 2014
<i>PARP1</i> gene variation and microglial activity on [<sup>11</sup>C]PBR28 PET in older adults at risk for Alzheimer's diseaseSungeun Kim, Kwangsik Nho, Shannon L Risacher, et al.
Neuroimage. Clinical|February 3, 2019
Resting state network modularity along the prodromal late onset Alzheimer's disease continuumJoey A Contreras, Andrea Avena-Koenigsberger, Shannon L Risacher, et al.
Brain Pathology (Zurich, Switzerland)|September 4, 2009
PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker diseaseVladimir Kepe, Bernardino Ghetti, Martin R Farlow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2023
Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN studyYing Xu, Htein Linn Aung, Randall J Bateman, et al.
Cell Reports|January 20, 2024
Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's diseaseMeichen Yu, Shannon L Risacher, Kwangsik T Nho, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Spatial transcriptomic patterns underlying regional vulnerability to amyloid-β and tau pathologies and their relationships to cognitive dysfunction in Alzheimer's diseaseMeichen Yu, Shannon L Risacher, Kwangsik T Nho, et al.
JAMA Neurology|April 19, 2016
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older AdultsShannon L Risacher, Brenna C McDonald, Eileen F Tallman, et al.
Pageof 19